Deep Phenotypic Characterisation of CTCs by Combination of Microfluidic Isolation (IsoFlux) and Imaging Flow Cytometry (ImageStream).

dc.contributor.authorRuiz-Rodríguez, Antonio J
dc.contributor.authorMolina-Vallejo, Maria P
dc.contributor.authorAznar-Peralta, Inés
dc.contributor.authorGonzález Puga, Cristina
dc.contributor.authorCañas García, Inés
dc.contributor.authorGonzález, Encarna
dc.contributor.authorLorente, Jose A
dc.contributor.authorSerrano, M Jose
dc.contributor.authorGarrido-Navas, M Carmen
dc.date.accessioned2025-01-07T14:05:27Z
dc.date.available2025-01-07T14:05:27Z
dc.date.issued2021-12-20
dc.description.abstractThe isolation of circulating tumour cells (CTCs) in colorectal cancer (CRC) mostly relies on the expression of epithelial markers such as EpCAM, and phenotypic characterisation is usually performed under fluorescence microscopy with only one or two additional markers. This limits the ability to detect different CTC subpopulations based on multiple markers. The aim of this work was to develop a novel protocol combining two platforms (IsoFluxTM and ImageStream®X) to improve CTC evaluation. Cancer cell lines and peripheral blood from healthy donors were used to evaluate the efficiency of each platform independently and in combination. Peripheral blood was extracted from 16 early CRC patients (before loco-regional surgery) to demonstrate the suitability of the protocol for CTC assessment. Additionally, peripheral blood was extracted from nine patients one month after surgery to validate the utility of our protocol for identifying CTC subpopulation changes over time. Results: Our protocol had a mean recovery efficiency of 69.5% and a limit of detection of at least four cells per millilitre. We developed an analysis method to reduce noise from magnetic beads used for CTC isolation. CTCs were isolated from CRC patients with a median of 37 CTCs (IQ 13.0-85.5) at baseline. CTCs from CRC patients were significantly (p
dc.identifier.doi10.3390/cancers13246386
dc.identifier.issn2072-6694
dc.identifier.pmcPMC8699219
dc.identifier.pmid34945008
dc.identifier.pubmedURLhttps://pmc.ncbi.nlm.nih.gov/articles/PMC8699219/pdf
dc.identifier.unpaywallURLhttps://www.mdpi.com/2072-6694/13/24/6386/pdf?version=1640090376
dc.identifier.urihttps://hdl.handle.net/10668/26133
dc.issue.number24
dc.journal.titleCancers
dc.journal.titleabbreviationCancers (Basel)
dc.language.isoen
dc.organizationSAS - Hospital Universitario San Cecilio
dc.organizationSAS - Hospital Universitario San Cecilio
dc.organizationSAS - Hospital Universitario Virgen de las Nieves
dc.organizationCentro Pfizer-Andalucía de Genómica e Investigación Oncológica (GENYO)
dc.organizationSAS - Hospital Universitario San Cecilio
dc.organizationInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA)
dc.pubmedtypeJournal Article
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectCRC
dc.subjectCTC heterogeneity
dc.subjectImageStream
dc.subjectIsoFlux
dc.subjectcirculating tumour cells
dc.titleDeep Phenotypic Characterisation of CTCs by Combination of Microfluidic Isolation (IsoFlux) and Imaging Flow Cytometry (ImageStream).
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number13

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
PMC8699219.pdf
Size:
2.13 MB
Format:
Adobe Portable Document Format